Business News • PR NewsWire • Sequana Medical Announces First Satellite Symposium and Key Data from its European Randomized Controlled Trial of the alfapump® System to be Presented at The International Liver Congress™ (ILC) 2016 in Barcelona, Spain, on 16 April 2016

Sequana Medical Announces First Satellite Symposium and Key Data from its European Randomized Controlled Trial of the alfapump® System to be Presented at The International Liver Congress™ (ILC) 2016 in Barcelona, Spain, on 16 April 2016

Sequana Medical Announces First Satellite Symposium and Key Data from its European Randomized Controlled Trial of the alfapump® System to be Presented at The International Liver Congress™ (ILC) 2016 in Barcelona, Spain, on 16 April 2016

ZURICH, April 14, 2016 /PRNewswire/ -- Sequana Medical AG, a privately held medical device company focused on the development and commercialization of innovative, implantable pump systems that manage fluid build-up occurring in patients with liver disease, certain cancers and congestive...

View More : http://www.prnewswire.com/news-releases/sequana-medical-announces-first-satellite-symposium-and-key-data-from-its-europe...

Releted News by prnewswire

ASAlaser for Runners

O CSA Group Abre Novo Laboratório em Tóquio, Japão